Catalyst Wire Dossier Catalyst Wire Dossier

Sustained-Release Liothyronine Sodium (T3)

liothyronine sodium
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Sustained-Release Liothyronine Sodium (T3), covering 2012-08-06 to 2012-08-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Sustained-Release Liothyronine Sodium (T3) in Healthy Subjects [Phase 1]

See pricing